Ulcerative colitis

@article{Ford2013UlcerativeC,
  title={Ulcerative colitis},
  author={A. Ford and P. Moayyedi and S. Hanauer},
  journal={BMJ : British Medical Journal},
  year={2013},
  volume={346}
}
Ulcerative colitis is an inflammatory disorder of the gastrointestinal tract that affects the colorectum. It often presents in young adulthood and is more common in developed nations. The diagnosis is reached after lower gastrointestinal investigation confirms diffuse, continuous, and superficial inflammation in the large bowel and biopsies show changes in keeping with the disorder. There is no single known unifying cause, and the pathogenesis probably relates to a change in colonic environment… Expand
A comprehensive review and update on ulcerative colitis.
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that causes continuous mucosal inflammation extending from the rectum to the more proximal colon, withExpand
Mesalamine in the Initial Therapy of Ulcerative Colitis.
TLDR
Doses of more than 2.4 g/d achieve significantly higher rates of clinical and endoscopic remission, with a decreased risk of relapse, and is considered safe in pregnancy, excluding formulations with dibutyl phthalate. Expand
New concepts in ulcerative colitis : A thin line between medicine and surgery
TLDR
Evidence elaborated in this thesis support the idea that a defective function and interaction with gut flora in the appendix play an essential role in the aetiology and probably also in the onset of UC. Expand
The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review
TLDR
Dysbiosis in the oral microbiome associated with IBD remains an emerging field for future research and viruses, and specially bacteriophages, can play a role in controlling microbial populations in the gastrointestinal tract. Expand
Vasculitis leucocitoclásticas como manifestación extraintestinal dermatológica rara de la enfermedad inflamatoria intestinal asociada con Clostridium: reporte de un caso
TLDR
A practical review of the pathophysiology, histology, treatment, and diagnosis of a rare dermatologic extraintestinal manifestation, namely, leukocytoclastic vasculitis, in patients with C. difficile–associated ulcerative colitis is reviewed. Expand
Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?
TLDR
The treatment goals for UC are examined and the efficacy of each therapy to reach these targets are reviewed, including mesalamines, steroids, immunomodulators, and biologics, including the first anti-integrin inhibitor, approved in May 2014, for the treatment of UC. Expand
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
TLDR
Fecal microbiota transplantation induces remission in a significantly greater percentage of patients with active UC than placebo, with no difference in adverse events. Expand
Postoperative diagnostic revision for Crohn disease after subtotal colectomy for inflammatory bowel disease
TLDR
Attention must be paid to determine the right restorative strategy to patients with an evolution of the disease less than 10 years or with IBDU who are more at risk to have a diagnosis change to CD after STC. Expand
Expression of VAChT and 5-HT in Ulcerative colitis dendritic cells.
TLDR
The human gut dendritic cells of ulcerative colitis patients are characterized for the first time with Langerin/CD207 that is a c-type lectin expressed by different types of DCs and colocalize in the same cells the expression of serotonin and vesicular acetylcholine transporter, showing the link between d endritic cells, gut enterochromaffin cells or autonomic nerves in immune activation and generation of intestinal inflammation. Expand
Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial
TLDR
This is the first randomized controlled clinical study protocol regarding Chinese herbal extract granules in the management of moderately active UC and aims to investigate the superiority of QCHS granules over placebo in terms of induction of remission. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 116 REFERENCES
Microscopic colitis
TLDR
Sufficient evidence exists to suggest that microscopic colitis occurs as a response to one or more luminal antigens, and only colloidal bismuth and budesonide have thus far been shown to be effective in randomized controlled trials. Expand
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
TLDR
Both UC and CD exhibit a relapsing and remitting course and there is a reduced quality of life during exacerbations of the disease, which has an impact on psychological health, with active IBD patients experiencing greater levels of distress and feelings of lack of sense of self-control compared with the normal population and patients with inactive IBD. Expand
Probiotics for induction of remission in ulcerative colitis.
TLDR
There is limited evidence that probiotics added to standard therapy may provide modest benefits in terms of reduction of disease activity in patients with mild to moderately severe ulcerative colitis, and larger randomised controlled trials are needed to determine whether probiotics can be used as an alternative to current treatment modalities. Expand
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.
TLDR
The aim of the Consensus is to promote a European perspective on the management of ulcerative colitis and its dilemmas to avoid duplication of effort in the future. Expand
Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update
TLDR
Fecal lactoferrin and calprotectin tests seem to be one step further from other tests with larger number of studies, higher sensitivity and specificity and wider availability. Expand
European evidence-based Consensus on the management of ulcerative colitis: Current management.
TLDR
The simplest, best validated and most widely used index for identifying acute severe UC remains that of Truelove & Wi_tts 3: any patient who has a bloody stool frequency ≥ 6/day and a tachycardia and temperature > 37.8 °C, or anaemia has severe ulcerative colitis. Expand
Guidelines for the management of inflammatory bowel disease in adults
TLDR
These guidelines, commissioned by the Clinical Services’ Committee of the British Society of Gastroenterology, provide an evidence based document describing good clinical practice for investigation and treatment of patients with IBD in the United Kingdom. Expand
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
TLDR
It is most important to distinguish patients with severe ulcerative colitis necessitating hospital admission from those with mild or moderately active disease who can generally be managed as outpatients, and to confirm the presence of active colitis by sigmoidoscopy before starting treatment. Expand
A meta-analysis on the influence of inflammatory bowel disease on pregnancy
TLDR
The study has shown a higher incidence of adverse pregnancy outcomes in patients with IBD, who should be treated as a potentially high-risk group. Expand
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
TLDR
Biological therapies were superior to placebo in inducing remission of active CD and UC, and in preventing relapse of quiescent CD. Expand
...
1
2
3
4
5
...